newsfilter
← Latest News
GlobeNewswire·

Evaxion announces business update and full year 2025 financial results

COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business update and